<DOC>
	<DOC>NCT00700076</DOC>
	<brief_summary>Org 25935 is a new putative antipsychotic agent developed by N.V. Organon.The primary objective of this study is to investigate the effect of Org 25935 on ketamine-induced impairments in immediate recall.</brief_summary>
	<brief_title>Pilot Study of ORG 25935 Modulation of Ketamine-induced Behavioral and Cognitive Effects in Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ketamine</mesh_term>
	<criteria>Male, 18 55 years History of sensitivity/idiosyncrasy to the drugs used in the study or chemically related compounds or excipients which may be employed in the study or to any other unknown drug used in the past.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>ORG 25935</keyword>
	<keyword>Ketamine</keyword>
	<keyword>healthy subjects</keyword>
</DOC>